BIOMAT Database Logo BIOMAT Database Logo

[Hemodynamic effects of isosorbide dinitrate (Isomack Retard capsules) in chronic heart failure]. 1988

M Stejfa, and J Vítovec, and M Blaha, and P Roubalík

UI MeSH Term Description Entries
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
September 1975, American heart journal,
M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
[Hemodynamic effects of intravenous isosorbide dinitrate in chronic heart failure (author's transl)].
April 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
October 1987, Clinical cardiology,
M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.
November 1974, Circulation,
M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
Isosorbide dinitrate in acute and chronic heart failure.
January 1979, Clinical pharmacology and therapeutics,
M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
[Hemodynamic effects of oral dihydralazine and sublingual isosorbide dinitrate, alone and in combination in chronic heart failure].
December 1979, Archives des maladies du coeur et des vaisseaux,
M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
[Hemodynamic effects of combined isosorbide dinitrate-nifedipine therapy in congestive heart failure (author's transl)].
September 1981, Kokyu to junkan. Respiration & circulation,
M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
[Duration of effects of isosorbide dinitrate retard in coronary disease].
November 1977, Die Medizinische Welt,
M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
September 1975, Circulation,
M Stejfa, and J Vítovec, and M Blaha, and P Roubalík
[Vasodilator therapy in congestive heart failure--hemodynamic effects of oral administered isosorbide dinitrate (author's transl)].
July 1978, Kokyu to junkan. Respiration & circulation,
Copied contents to your clipboard!